SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010379
Filing Date
2021-08-05
Accepted
2021-08-05 07:05:29
Documents
86
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcyc-20210630x10q.htm   iXBRL 10-Q 2396017
2 EX-4.1 bcyc-20210630xex4d1.htm EX-4.1 29004
3 EX-31.1 bcyc-20210630xex31d1.htm EX-31.1 13982
4 EX-31.2 bcyc-20210630xex31d2.htm EX-31.2 13999
5 EX-32.1 bcyc-20210630xex32d1.htm EX-32.1 10820
6 GRAPHIC bcyc-20210630xex4d1001.jpg GRAPHIC 939
  Complete submission text file 0001558370-21-010379.txt   8906803

Data Files

Seq Description Document Type Size
7 EX-101.SCH bcyc-20210630.xsd EX-101.SCH 74749
8 EX-101.CAL bcyc-20210630_cal.xml EX-101.CAL 52065
9 EX-101.DEF bcyc-20210630_def.xml EX-101.DEF 275200
10 EX-101.LAB bcyc-20210630_lab.xml EX-101.LAB 533759
11 EX-101.PRE bcyc-20210630_pre.xml EX-101.PRE 431578
12 EXTRACTED XBRL INSTANCE DOCUMENT bcyc-20210630x10q_htm.xml XML 1387546
Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Filer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38916 | Film No.: 211146254
SIC: 2834 Pharmaceutical Preparations